WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008094942) HUMANIZED ANTIBODIES AGAINST CXCR3
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/094942    International Application No.:    PCT/US2008/052356
Publication Date: 07.08.2008 International Filing Date: 29.01.2008
IPC:
C07K 16/28 (2006.01), A61K 39/395 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01), A61P 37/00 (2006.01)
Applicants: TEVA BIOPHARMACEUTICALS USA, INC. [US/US]; 9410 Key West Avenue, Rockville, MD 20850 (US) (For All Designated States Except US).
SMITH, Rodger [US/US]; (US) (For US Only).
KANAKARAJ, Palanisamy [US/US]; (US) (For US Only).
ROSCHKE, Viktor [RU/US]; (US) (For US Only)
Inventors: SMITH, Rodger; (US).
KANAKARAJ, Palanisamy; (US).
ROSCHKE, Viktor; (US)
Agent: SIMKIN, Michele, M.; Foley & Lardner LLP, Washington Harbour, 3000 K St., NW, Suite 500, Washington, DC 20007 (US)
Priority Data:
60/898,709 01.02.2007 US
Title (EN) HUMANIZED ANTIBODIES AGAINST CXCR3
(FR) ANTICORPS HUMANISÉS CONTRE CXCR3
Abstract: front page image
(EN)Disclosed are humanized antibodies that bind specifically to the receptor CXCR3. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with CXCR3 function.
(FR)L'invention concerne des anticorps humanisés se liant spécifiquement au récepteur CXCR3. Les anticorps humanisés peuvent être des antagonistes et peuvent être utilisés pour traiter ou diagnostiquer des affections associées à la fonction CXCR3.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)